CipherBio Weekly Digest: Week of Feb 10 – Feb 16, 2022
This week our life science funding digest reports $2.77B in deals and $391.90M in Series A. We also added 105 companies and 42 investors to our platform.
New Companies on CipherBio
New Investors on CipherBio
Top Deals This Week
Upstream Bio, Cambridge-based biotech, raises $200M in Series A round led by Orbimed. A FoodTech company Next Gen Foods raises $100M in Series A from Temasek Holdings, K3 Ventures, GGV Capital and others. Leyden Labs raises $140M in Series B led by Casdin Capital and GV. Also in Series B Third Harmonic Bio raises $105M led by General Atlantic and BVF Partners. Kallyope gets $150M in Series D led by Mubadala Investment Company and The Column Group. Collegium Pharmaceutical acquires BioDelivery Sciences in an all-cash deal worth up to $604M.
|Upstream Bio||Series A||$200M|
|Next Gen Foods||Series A||$100M|
|Leyden Labs||Series B||$140M|
|Third Harmonic Bio||Series B||$105M|
Funds Raised This Week
ACME Capital, San Francisco VC, raises $300M in ACME Fund IV from undisclosed investors. Asia Healthcare Holdings(AHH) raises $170M in Wealth Fund GIC from undisclosed investors. Unovis Asset Management closes $166M Unovis Asset Management’s Fund II from Unigestion, Invest-NL, Griffith Foods and others.
This Week’s Lead Investors in Top Rounds
This Week in Clinical Phases
In phase 1 Maze Therapeutics announces trial of MZE001 for Pompe Disease. Belgium-based Oxurion announces phase 2 clinical trial of THR-149. Revive Therapeutics is in phase 3 trial of Bucillamine. Motus GI got the FDA Clearance for its Pure-Vu® EVS System.
|Company||Product and Clinical Phase||Indications|
|Maze Therapeutics||MZE001, Phase 1||Pompe Disease|
|Oxurion||THR-149, Phase 2||Diabetic Macular Edema|
|Revive Therapeutics||Bucillamine, Phase 3||Liver Diseases, Autoimmune Hepatitis, COVID-19|
|Motus GI||Pure-Vu® EVS System, FDA Cleared||Gastrointestinal Diseases|
Starfield, food & science technology, raised $100M in Series B round led by Primavera Capital Group, Lightspeed China Partners and Joy Capital. FlipDish raised $100M in Series C led by Tencent. In AgTech MycoWorks raised $125M in Series C to build a new alt-leather factory. WayCool raised $117M in Series D led by LightRock, LightBox, FMO and others.
105 Life Science Companies Added
This week we added 154 funding events, 105 life science companies and 42 investors.
|Ada Health||Splendid Spoon||LinKinVax|
|Respira Labs||PhaseBio Pharmaceuticals||Bodymatter|
|Elo Health||Birmingham Biotech||Protix|
|Endless West||Celeris Therapeutics||Mindstate Design Labs|
To get all the latest life science deals and VC funding data delivered straight to your inbox weekly become a CipherBio PRO member.